AKT1 and Familial prostate cancer: The compounds referred to as OSU03012 and OSU03013 inhibited PDK-1 kinase activity in vitro (50% inhibitory concentration 2–5 μmol/l) and prevented Akt phosphorylation in prostate cancer cells at 1–10 μmol/l.